# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-25-041614
Filing Date
2025-05-09
Accepted
2025-05-09 17:27:35
Documents
49
Period of Report
2025-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | QUARTERLY REPORT | ea0239143-10q_actinium.htm iXBRL | 10-Q | 751811
2 | CERTIFICATION | ea023914301ex31-1_actinium.htm | EX-31.1 | 9785
3 | CERTIFICATION | ea023914301ex31-2_actinium.htm | EX-31.2 | 9824
4 | CERTIFICATION | ea023914301ex32-1_actinium.htm | EX-32.1 | 3815
5 | CERTIFICATION | ea023914301ex32-2_actinium.htm | EX-32.2 | 3854
6 | GRAPHIC | image_001.jpg | GRAPHIC | 119463
7 | GRAPHIC | image_002.jpg | GRAPHIC | 80255
8 | GRAPHIC | image_003.jpg | GRAPHIC | 54445
| Complete submission text file | 0001213900-25-041614.txt |  | 4227769

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
9 | XBRL SCHEMA FILE | atnm-20250331.xsd | EX-101.SCH | 24106
10 | XBRL CALCULATION FILE | atnm-20250331_cal.xml | EX-101.CAL | 25061
11 | XBRL DEFINITION FILE | atnm-20250331_def.xml | EX-101.DEF | 133812
12 | XBRL LABEL FILE | atnm-20250331_lab.xml | EX-101.LAB | 298184
13 | XBRL PRESENTATION FILE | atnm-20250331_pre.xml | EX-101.PRE | 149359
51 | EXTRACTED XBRL INSTANCE DOCUMENT | ea0239143-10q_actinium_htm.xml | XML | 264010

Mailing Address 100 PARK AVE., 23RD FLOOR NEW YORK NY 10017
Business Address 100 PARK AVE., 23RD FLOOR NEW YORK NY 10017 (646) 677-3870
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36374 | Film No.: 25931824
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)